{
    "nct_id": "NCT00777608",
    "title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial, With Placebo Run-In, and an Open-Label Treatment Period, to Evaluate the Performance of the CogState Computerized Neuropsychological Battery and the ADAS-Cog in Generally Cholinesterase-naive AD Patients",
    "status": "COMPLETED",
    "last_update_time": "2015-08-11",
    "description_brief": "This study will evaluate the performance of the CogState computerized neuropsychological battery, Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog) and Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL) in participants with mild-to-moderate Alzheimer's disease (AD).",
    "description_detailed": "N/A",
    "phase": [
        "PHASE1"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Donepezil 5-10 mg",
                    "description": "Participants were randomized to donepezil for 84 days"
                },
                {
                    "id": "FG001",
                    "title": "Placebo",
                    "description": "Participants were randomized to placebo for 84 days"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "53"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "53"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "49"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "47"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "6"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Lost to Follow-up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "3"
                                }
                            ]
                        },
                        {
                            "type": "Protocol Violation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Investigator Decision",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Donepezil 5-10 mg",
                    "description": "Participants were randomized to donepezil for 84 days"
                },
                {
                    "id": "BG001",
                    "title": "Placebo",
                    "description": "Participants were randomized to placebo for 84 days"
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "53"
                        },
                        {
                            "groupId": "BG001",
                            "value": "53"
                        },
                        {
                            "groupId": "BG002",
                            "value": "106"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Customized",
                    "description": "Age \\>= 55 years",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "53"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "53"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "106"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "23"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "45"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "30"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "31"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "61"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change in Mean Computer-based Cognitive Assessment (CogState) Composite Score at Week 4",
                    "description": "CogState is a simple, brief computerized neuropsychological battery to evaluate cognitive impairments characterizing mild-to-moderate Alzheimer's Disease (AD). The composite CogState assesses attention and memory functions - including Verbal episodic memory, Visual Episodic Memory, Psychomotor function, Visual attention and working memory. CogState scores are measured on a linear scale (with no maximum score) and a reduction in scores compared to baseline indicates an improvement in cognitive functions. Reported here is the change in the CogState Composite Score at Week 4 compared to baseline.",
                    "populationDescription": "The analysis for the primary and secondary CogState endpoints was done on a per protocol basis (only participants who were compliant and successfully tolerated the forced titration after 2 weeks of treatment were included in the analysis).",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Score on a scale",
                    "timeFrame": "Baseline and 4 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Donepezil 5-10 mg",
                            "description": "Participants were randomized to donepezil for 84 days"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Participants were randomized to placebo for 84 days"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "38"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "43"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.10",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.07",
                                            "spread": "0.06"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.231",
                            "statisticalMethod": "ANOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.07",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.2",
                            "ciUpperLimit": "0.08"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Evaluate the Efficacy of Donepezil by Determining the Change in Mean CogState Composite Score at Week 2, Week 8 and Week 12",
                    "description": "CogState is a simple, brief computerized neuropsychological battery to evaluate cognitive impairments characterizing mild-to-moderate Alzheimer's Disease (AD). The composite CogState assesses attention and memory functions - including Verbal episodic memory, Visual Episodic Memory, Psychomotor function, Visual attention and working memory. CogState scores are measured on a linear scale (no maximum score) and a reduction in scores compared to baseline indicates an improvement in cognitive functions. Reported here is the change from baseline in the CogState Composite Score at Weeks 4, 8 and 12.",
                    "populationDescription": "The analysis for the primary and secondary CogState endpoints was done on a per protocol basis (only participants who were compliant and successfully tolerated the forced titration after 2 weeks of treatment were included in the analysis).",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Score on a scale",
                    "timeFrame": "Baseline and 2 weeks, 8 weeks and 12 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Donepezil 5-10 mg",
                            "description": "Participants were randomized to donepezil for 84 days"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Participants were randomized to placebo for 84 days"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "38"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "43"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Week 2 (N=38, N=43)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.2",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.006",
                                            "spread": "0.06"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 8 (N=38, N=40)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.1",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.02",
                                            "spread": "0.07"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 12 (N=38, N=41)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.2",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.09",
                                            "spread": "0.07"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.041",
                            "statisticalMethod": "ANOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.2",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.3",
                            "ciUpperLimit": "-0.008",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.09",
                            "estimateComment": "Statistical analysis for Week 2"
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.143",
                            "statisticalMethod": "ANOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.1",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.3",
                            "ciUpperLimit": "0.06",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.09",
                            "estimateComment": "Statistical analysis for Week 8"
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.226",
                            "statisticalMethod": "ANOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.07",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.2",
                            "ciUpperLimit": "0.09",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.10",
                            "estimateComment": "Statistical analysis for Week 12"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Evaluate the Efficacy of Donepezil by Determining the Change in Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) Score at Week 4, Week 8 and Week 12",
                    "description": "The ADAS-Cog is a psychometric instrument that evaluates memory, attention,\n\nreasoning, language, orientation and praxis using an 11-point AD Assessment Scale. It has a minimum score of 0 and a maximum severity score of 70, and a higher score indicates more impairment. A reduction in scores compared to baseline indicates an improvement in cognitive functions. Reported here is the change in the ADAS-Cog score at Weeks 4, 8 and 12 compared to baseline.",
                    "populationDescription": "The analysis for the primary and secondary CogState endpoints was done on a per protocol basis (only participants who were compliant and successfully tolerated the forced titration after 2 weeks of treatment were included in the analysis).",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Score on a scale",
                    "timeFrame": "Baseline and 4 weeks, 8 weeks and 12 weeks.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Donepezil 5-10 mg",
                            "description": "Participants were randomized to donepezil for 84 days"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Participants were randomized to placebo for 84 days"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "38"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "43"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Week 4 (N=38, N=43)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.2",
                                            "spread": "0.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.3",
                                            "spread": "0.7"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 8 (N=37, N=40)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.07",
                                            "spread": "1.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.7",
                                            "spread": "1.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 12 (N=38, N=40)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.4",
                                            "spread": "1.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.0",
                                            "spread": "1.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.324",
                            "statisticalMethod": "ANOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.5",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-1.2",
                            "ciUpperLimit": "2.2",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.0",
                            "estimateComment": "Statistical analysis for Week 4"
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.285",
                            "statisticalMethod": "ANOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.8",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-1.5",
                            "ciUpperLimit": "3.1",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.4"
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.401",
                            "statisticalMethod": "ANOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.3",
                            "ciPctValue": "90",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-2.6",
                            "ciUpperLimit": "1.9",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.3",
                            "estimateComment": "Statistical analysis for Week 12"
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Donezepil 5-10 mg",
                    "description": "Participants were randomized to donepezil for 84 days",
                    "seriousNumAffected": 3,
                    "seriousNumAtRisk": 53,
                    "otherNumAffected": 10,
                    "otherNumAtRisk": 53
                },
                {
                    "id": "EG001",
                    "title": "Placebo",
                    "description": "Participants were randomized to placebo for 84 days",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 53,
                    "otherNumAffected": 9,
                    "otherNumAtRisk": 53
                }
            ],
            "seriousEvents": [
                {
                    "term": "Inguinal hernia",
                    "organSystem": "Gastrointestinal disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        }
                    ]
                },
                {
                    "term": "Head Injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        }
                    ]
                },
                {
                    "term": "Subdural haematoma",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        }
                    ]
                },
                {
                    "term": "Convulsion",
                    "organSystem": "Nervous system disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        }
                    ]
                },
                {
                    "term": "Urinary incontinence",
                    "organSystem": "Renal and urinary disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Nausea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 12.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 7,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 5,
                            "numAtRisk": 53
                        }
                    ]
                },
                {
                    "term": "Dizziness",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 12.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 4,
                            "numAtRisk": 53
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Senior Vice President, Global Clinical Development",
                "organization": "Merck Sharp and Dohme Corp",
                "email": "ClinicalTrialsDisclosure@merck.com"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "Donepezil (5 mg \u2192 10 mg; optional open\u2011label 10 mg)"
    ],
    "placebo": [
        "Matching placebo (placebo run\u2011in and placebo comparator)"
    ],
    "explanation_target": [
        "Reason: The trial tests a cholinesterase\u2011naive Alzheimer\u2019s population with donepezil as the interventional drug and uses cognitive scales (CogState composite, ADAS\u2011Cog, ADCS\u2011ADL) as primary/secondary outcomes, indicating the aim is symptomatic cognitive improvement rather than disease modification. \ue200cite\ue202turn1search0\ue202turn1search4\ue201",
        "Act: Key extracted details \u2014 trial NCT00777608 (Multicenter, randomized, double\u2011blind, placebo\u2011controlled with placebo run\u2011in and open\u2011label period) lists donepezil as the active drug (initial 5 mg for 14 days then titrate to 10 mg for 70 days; optional open\u2011label 10 mg for 24 weeks) and includes matching placebo arms. Primary outcome is change in CogState composite and ADAS\u2011Cog/ADCS\u2011ADL are used to evaluate efficacy. \ue200cite\ue202turn1search0\ue202turn1search2\ue201",
        "Act (mechanism): Donepezil is a centrally acting, reversible acetylcholinesterase inhibitor (a small\u2011molecule drug) that increases synaptic acetylcholine to produce modest symptomatic improvement in cognition in AD; it is not considered disease\u2011modifying. Based on mechanism and intended clinical endpoints, this fits the 'cognitive enhancer' category. \ue200cite\ue202turn2search3\ue202turn2search5\ue201",
        "Reflect: Classification check \u2014 the intervention is a small\u2011molecule cholinesterase inhibitor used to improve cognition (not a biologic targeting amyloid/tau nor an agent aimed primarily at neuropsychiatric symptoms). Therefore the appropriate category is 'cognitive enhancer'. No substantial ambiguity: trial documents explicitly name donepezil and describe cognitive outcome measures. \ue200cite\ue202turn1search0\ue202turn2search3\ue201",
        "Web search results (sources used): Clinical trial record and results summary showing donepezil as intervention and study design (NCT00777608). \ue200cite\ue202turn1search0\ue202turn1search1\ue201; Study registry entry summarizing arms and dosing. \ue200cite\ue202turn1search4\ue201; Mechanism and pharmacology references describing donepezil as a reversible acetylcholinesterase inhibitor and symptomatic cognitive enhancer (StatPearls, RxReasoner). \ue200cite\ue202turn2search3\ue202turn2search5\ue201"
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: The trial tests donepezil, a centrally acting, reversible acetylcholinesterase inhibitor intended to increase synaptic acetylcholine and produce symptomatic cognitive benefit (cognitive enhancer) rather than modify underlying AD pathology; this mechanism modulates the cholinergic neurotransmitter system and fits CADRO's neurotransmitter-targeting category. \ue200cite\ue202turn0search2\ue202turn0search3\ue201",
        "Act: Extracted details \u2014 intervention = donepezil (5 mg \u2192 10 mg, optional open\u2011label 10 mg); population = cholinesterase\u2011naive AD patients; primary outcomes = CogState composite and ADAS\u2011Cog (symptomatic cognitive scales). Mechanism = inhibition of acetylcholinesterase (increases acetylcholine availability at synapses). Based on these specifics, assign D) Neurotransmitter Receptors. \ue200cite\ue202turn0search6\ue202turn0search2\ue201",
        "Reflect: Verification \u2014 donepezil is a small\u2011molecule cholinesterase inhibitor used for symptomatic cognitive improvement in AD (not primarily amyloid/tau, inflammation, or other disease\u2011modifying targets). CADRO best match is D) Neurotransmitter Receptors (cholinergic system modulation). There is no indication of multiple biological targets requiring 'R) Multi-target' nor a non\u2011therapeutic focus requiring 'T) Other'. \ue200cite\ue202turn0search5\ue202turn0search1\ue201",
        "Web search results / sources used: clinical trial record and results summary for NCT00777608 (trial design, dosing, CogState and ADAS\u2011Cog endpoints). \ue200cite\ue202turn0search6\ue201; StatPearls summary describing donepezil mechanism as a reversible acetylcholinesterase inhibitor that increases synaptic acetylcholine. \ue200cite\ue202turn0search2\ue201; Key clinical trial publications showing donepezil improves ADAS\u2011Cog and other cognitive measures in AD. \ue200cite\ue202turn0search3\ue202turn0search1\ue201; Systematic reviews/meta\u2011analyses (Cochrane, PubMed) summarizing symptomatic benefits of donepezil in AD. \ue200cite\ue202turn0search5\ue202turn0search0\ue201"
    ]
}